PloS one

medical hypotheses

journal of clinical neuroscience : official journal of the neurosurgical society of australasia

therapeutic advances in cardiovascular disease

European journal of medical genetics

expert opinion on pharmacotherapy

Cardiology clinics

[1] Advances in the pharmacological management of obsessive-compulsive disorder in the postpartum period.

[2] Hydroxychloroquine as an aerosol might markedly reduce and even prevent severe clinical symptoms after SARS-CoV-2 infection.

[3] Maximizing the Adequacy of Medication Treatment in Controlled Trials and Clinical Practice: STAR*D Measurement-Based Care

[4] Treatment of Infectious Diarrhea in Children

[5] Report by the ACNP Task Force on Response and Remission in Major Depressive Disorder

[6] japanese guideline for atopic dermatitis 2014

[7] transcranial direct current stimulation: challenges, opportunities and impact on psychiatry and neurorehabilitation

[8] japanese guideline for allergic rhinitis 2014

[9] pharmacotherapy for alcohol use disorders: physicians’ perceptions and practices

[10] Effect of Severe Renal Failure and Haemodialysis on the Pharmacokinetics of Levosimendan and Its Metabolites - Clinical Pharmacokinetics

[11] Management of Essential Hypertension.

[12] Adherence to Short-course Pharmacotherapy in Adults with Irritable Bowel Syndrome.

[13] A longitudinal perspective on the pharmacotherapy of 24 adult patients with Phelan McDermid syndrome.

[14] Progress in pediatrics in 2011. Choices in endocrinology, gastroenterology, hemato-oncology, infectious diseases, otolaryngology, pharmacotherapy and respiratory tract illnesses

[15] Pharmacotherapy for personality disorder-prescribing practice at a high secure hospital: a preliminary report.

[16] Pulmonary hypertension associated with idiopathic interstitial pneumonia: is effective pharmacotherapy an impossible dream?

[17] Pharmacotherapy for metabolic and cellular stress in degenerative retinal diseases.

[18] Randomized comparison of renal denervation versus intensified pharmacotherapy including spironolactone in true-resistant hypertension: six-month results from the Prague-15 study.

[19] Self-monitoring and treatment of chronic non-communicable diseases in the context of the COVID-19 pandemic. Consensus of experts of the National society of evidence-based pharmacotherapy and the Russian society of the prevention of non-communicable diseases

[20] Pharmacotherapy of paediatric epilepsy

[21] The Pharmacotherapy of Panic Disorder

[22] Cost-Effectiveness of Prolonged Exposure Therapy Versus Pharmacotherapy and Treatment Choice in Posttraumatic Stress Disorder (the Optimizing PTSD Treatment Trial): A Doubly Randomized Preference Trial

[23] The Increasing Use of Polypharmacotherapy for Refractory Mood Disorders: 22 Years of Study

[24] briefing note about activity of editorial board of “rational pharmacotherapy in cardiology” in 2012

[25] drug-induced gingival overgrowth and its tentative pharmacotherapy

[26] atrophic vulvovaginitis: new trends in pharmacotherapy

[27] influencing the decline of lung function in copd: use of pharmacotherapy

[28] pharmacotherapy in elderly neuropathic pain

[29] the emergence of extracellular vesicles in urology: fertility, cancer, biomarkers and targeted pharmacotherapy

[30] practical outpatient pharmacotherapy for alcohol use disorder

[31] recent advances in the pharmacotherapy of chronic anal fissure: an update

[32] pharmacotherapy of stomach diseases in dogs

[33] role of donepezil in autism: its conduciveness in psychopharmacotherapy

[34] hyperpharmacotherapy in ageing cystic fibrosis patients: the first report of an atypical hip fracture

[35] melatonin vs benzodiazepines in pharmacotherapy of insomnias: positive and negative sides of both (a review of the literature)

[36] Оptimization of pharmacotherapy of osteopenia in children with chronic pyelonephritis

[37] pharmacotherapy for alcohol use disorders: physicians’ perceptions and practices

[38] incorporating ulipristal acetate in the care of symptomatic uterine fibroids: a canadian cost-utility analysis of pharmacotherapy management

[39] Diagnosis and Pharmacotherapy of Bipolar Depression in Pediatric Patients

[40] Economic Outcomes With Antidepressant Pharmacotherapy: A Retrospective Intent-To-Treat Analysis

[41] Pharmacotherapy for Attention-Deficit/Hyperactivity Disorder (ADHD) Decreases the Risk for Substance Abuse: Findings From a Longitudinal Follow-Up of Youths With and Without ADHD

[42] August Podcast: Simplifying pharmacotherapy for patients with COPD